Company intelligence / Profile preview

SpineVision

Ownership: Private
Employees: ~70
Development stage: Commercial

Overview

SpineVision has developed and commercialized a portfolio of innovative spinal implants and instrumentation. Its technologies address approximately 90% of spinal pathologies with solutions for both open and minimally invasive procedures. Notable products include the Hexanium interbody cage using additive manufacturing for improved outcomes, as well as dynamic stabilization systems like Flex+2 and LUMIS. Clinical results are not detailed in public sources but the company emphasizes surgeon collaboration and patient-centered innovation.

Therapeutic areas: OtherOncologyNeurology
Modalities: DeviceImplantInstrumentation (for spinal surgery)
Industry: Implantable Medical Devices

Partnerships

Close collaborations with leading neurosurgeons/orthopedic surgeons including Dr. Reinhard Zeller & Pr. Ciaran Bolger.

Beyond the preview

Go deeper on SpineVision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpineVision.

Explore the full profile